Reranking cancer mortality using years of life lost
JNCI Cancer Spectrum · 2023
DOI: 10.1093/jncics/pkad038 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2023. Verfasst von Cecilia Radkiewicz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm.
Abstract (Originalsprache)
Incidence and mortality are default measures to describe cancer trends. Mortality compounds incidence and survival but not age at death. We calculated years of life lost (YLL) due to 1 of the 10 solid tumors causing most deaths (lung, colorectal, prostate, pancreatic, breast, hepatobiliary, urinary, central nervous system, gastric, melanoma) using Swedish National Cancer and Cause of Death Registers. Comparing YLL with mortality in 2019, lung (43 152 YLL) and colorectal (32 340 YLL) cancer remained at the top, pancreatic cancer was upranked fourth to third (22 592 YLL) and breast cancer fifth to fourth (21 810 YLL), while prostate cancer was downranked third to fifth (17 380 YLL). Assessing YLL over 2010-2019, women lost consistently more life years because of lung and pancreatic cancer. A downward colorectal cancer mortality trend was reflected as a YLL decline only in women. YLL is simple to calculate, is intuitive to interpret, and expands the understanding of the cancer burden on society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Surgery, Capio Sankt Görans Sjukhus, Stockholm, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- School of Cancer and Pharmaceutical Sciences, King's College London, UK.
ORCID-Profile: Cecilia Radkiewicz, Therese M-L Andersson, Jesper Lagergren
Förderung
- Region Stockholm
Zitieren
APA
Radkiewicz, C., Andersson, T. M., & Lagergren, J. (2023). Reranking cancer mortality using years of life lost. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkad038
Vancouver
Radkiewicz C, Andersson TM, Lagergren J. Reranking cancer mortality using years of life lost. JNCI Cancer Spectrum. 2023. doi:10.1093/jncics/pkad038
BibTeX
@article{Radkiewicz2023,
author = {Radkiewicz, Cecilia and Andersson, Therese M-L and Lagergren, Jesper},
title = {Reranking cancer mortality using years of life lost},
journal = {JNCI Cancer Spectrum},
year = {2023},
doi = {10.1093/jncics/pkad038}
}
EUVIMED